NCT05651555

Brief Summary

Moving into an institution is a new stage in the life of the patient but also of the caregiver. The caregiver is overwhelmed by various feelings such as loss of control, powerlessness, guilt, sadness, the feeling of loneliness at home but also relief. This experience can be characterized by great anxiety and the feeling of being misunderstood by the family and professional environment. This emotional state is not without consequences for the caregiver/resident and caregiver/care team relationship. Several factors have been identified that may be at the origin of these states. A new training, information and support program has been created to present these different factors to caregivers and to allow them to address them with professionals in a group setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 15, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

March 28, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 23, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2025

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

1.6 years

First QC Date

December 7, 2022

Last Update Submit

September 5, 2025

Conditions

Keywords

CaregivingPsychosocial interventionNursing home placementNursing home admissionInformal long-term care

Outcome Measures

Primary Outcomes (3)

  • HADS (Hospital Anxiety and Depression scale)

    Reduction in anxiety symptoms of 1 to 3 points according to the HADS Hospital Anxiety and Depression scale) between the start and the end of the program. The depression score assessed by the HADS will be measured. The maximum score that can be obtained for this sub-score is 21. is possible to determine the presence or not, as well as the intensity of the depressive disorder: absence of depressive disorder (score ranging from 0 to 7), suspected depressive disorder (score ranging from 8 to 10) and proven depressive disorder (score ranging from 11 to 21). Thus, the higher the score, the more severe the participant's symptomatology.

    Inclusion

  • HADS (Hospital Anxiety and Depression scale)

    Reduction in anxiety symptoms of 1 to 3 points according to the HADS Hospital Anxiety and Depression scale) between the start and the end of the program. The anxiety score assessed by the HADS will be measured. The maximum score that can be obtained for this sub-score is 21. Within the questionnaire, the order of scoring (from 0 to 3 or from 3 to 0) is alternated, in order to limit the bias linked to their repetition. Depending on the participants' scores on the depression subscale, it is possible to determine the presence or not, as well as the intensity of the depressive disorder: absence of depressive disorder (score ranging from 0 to 7), suspected depressive disorder (score ranging from 8 to 10) and proven depressive disorder (score ranging from 11 to 21). Thus, the higher the score, the more severe the participant's symptomatology. The first French validation of this scale was carried out by Lepine et al., 1985.

    Week 16 for the group N (T2)

  • HADS (Hospital Anxiety and Depression scale)

    Reduction in anxiety symptoms of 1 to 3 points according to the HADS Hospital Anxiety and Depression scale) between the start and the end of the program. The depression score assessed by the HADS will be measured. The maximum score that can be obtained for this sub-score is 21. Within the questionnaire, the order of scoring (from 0 to 3 or from 3 to 0) is alternated, in order to limit the bias linked to their repetition. Depending on the participants' scores on the depression subscale, it is possible to determine the presence or not, as well as the intensity of the depressive disorder: absence of depressive disorder (score ranging from 0 to 7), suspected depressive disorder (score ranging from 8 to 10) and proven depressive disorder (score ranging from 11 to 21). Thus, the higher the score, the more severe the participant's symptomatology. The first French validation of this scale was carried out by Lepine et al., 1985.

    Week 24 for the group C (T3)

Secondary Outcomes (38)

  • HADS (Hospital Anxiety and Depression scale)

    Week 8 (T1) for both groups

  • HADS (Hospital Anxiety and Depression scale)

    Week 16 for the group C (T2)

  • Zarit Caregiver Burden Scale

    Inclusion

  • Zarit Caregiver Burden Scale

    Week 8

  • Zarit Caregiver Burden Scale

    Week 16

  • +33 more secondary outcomes

Study Arms (2)

N arm

EXPERIMENTAL
Behavioral: Psycho-educational program EHPAD caregivers / Pact & Pad for caregivers with a parent in an institution

Control group

ACTIVE COMPARATOR
Behavioral: Psycho-educational program EHPAD caregivers / Pact & Pad for caregivers with a parent in an institution

Interventions

Psycho-educational program EHPAD caregivers / Pact \& Pad for caregivers with a parent in an institution

Control groupN arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Family caregivers defined according to the European charter for family caregivers COFACE: "the non-professional person who comes to the aid mainly, in part or totally, to a person dependent on his or her entourage, for activities of daily living. This regular help can be provided on a permanent basis or not and can take several forms, in particular: nursing, care, support for education and social life, administrative procedures, coordination, permanent vigilance, psychological support, communication, domestic activities. . Currently, these caregivers have an elderly relative living in an institution or in the process of institutionalization
  • Have been a caregiver for at least six months
  • Have a parent in an EHPAD for less than 25 weeks
  • The loved one is not at the end of life when the caregiver starts the program
  • Participate in at least five workshops out of the seven offered as part of the program.
  • Be of legal age (at least 18 years old)
  • Presence of depression or anxiety according to HAD
  • Be motivated to follow the program
  • Signature of consent.
  • Be affiliated with a social security scheme

You may not qualify if:

  • Caregiver with a loved one living at home without institutionalization plans
  • Professional caregivers, former caregivers
  • Absence of depression and/or anxiety
  • Deceased relative
  • Have untreated diagnosed psychiatric disorders
  • To be suffering from proven cognitive disorders
  • Already benefit from another caregiver assistance program.
  • Patient under AME
  • Vulnerable people

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique - Hôpitaux de Paris (AP-HP) - Broca Hospital - Geriatric unit

Paris, Île-de-France Region, 75013, France

Location

Related Publications (1)

  • Meziane-Damnee S, Bayle C, Pino M, Lenoir H, Cantegreil I, Rigaud AS. [A psycho-educational program for family caregivers of people with Alzheimer's disease entering an institution]. Soins Gerontol. 2023 May-Jun;28(161):20-23. doi: 10.1016/j.sger.2023.04.007. Epub 2023 Jun 1. French.

    PMID: 37328202BACKGROUND

MeSH Terms

Interventions

Protein-Arginine DeiminasesCaregivers

Intervention Hierarchy (Ancestors)

HydrolasesEnzymesEnzymes and CoenzymesHealth PersonnelHealth Care Facilities Workforce and Services

Study Officials

  • Anne-Sophie RIGAUD, MD, PhD, PU-PH

    Broca Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2022

First Posted

December 15, 2022

Study Start

March 28, 2023

Primary Completion

October 23, 2024

Study Completion

June 11, 2025

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations